Join
Live feed
·
PRReleasevia Quantisnow
IceCure Medical Ltd. logo

IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates

ByQuantisnow·Wall Street's wire, on your screen.
ICCM· IceCure Medical Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICCM (IceCure Medical Ltd.) and more on Quantisnow.